Maintenance of bimekizumab efficacy through 2 years in patients with moderate to severe plaque psoriasis: Pooled results from five phase 3/3b trials
Authors: Diamant Thaçi, April Armstrong, Mark Lebwohl, Andrew Blauvelt, Carle Paul, Luis Puig, Maggie Wang, Veerle Vanvoorden, Cynthia Madden, Susanne Wiegratz, Delphine Deherder, Kenneth B. Gordon